265 related articles for article (PubMed ID: 18765585)
1. Bilateral hilar foci on 18F-FDG PET scan in patients without lung cancer: variables associated with benign and malignant etiology.
Karam M; Roberts-Klein S; Shet N; Chang J; Feustel P
J Nucl Med; 2008 Sep; 49(9):1429-36. PubMed ID: 18765585
[TBL] [Abstract][Full Text] [Related]
2. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study.
Tournoy KG; Maddens S; Gosselin R; Van Maele G; van Meerbeeck JP; Kelles A
Thorax; 2007 Aug; 62(8):696-701. PubMed ID: 17687098
[TBL] [Abstract][Full Text] [Related]
3. Biopsy findings in PET/CT-positive lung lesions in a community hospital.
Lobrano MB; Hayman E; Dekelbaum M; Campeau R
J La State Med Soc; 2005; 157(6):319-24. PubMed ID: 16579344
[TBL] [Abstract][Full Text] [Related]
4. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
[TBL] [Abstract][Full Text] [Related]
6. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
7. Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm.
Brady MJ; Thomas J; Wong TZ; Franklin KM; Ho LM; Paulson EK
Radiology; 2009 Feb; 250(2):523-30. PubMed ID: 19188319
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
[TBL] [Abstract][Full Text] [Related]
9. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
Hu M; Yu JM; Liu NB; Liu LP; Guo HB; Yang GR; Zhang PL; Xu XQ
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):306-9. PubMed ID: 18788639
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies.
O JH; Yoo IeR; Kim SH; Sohn HS; Chung SK
J Nucl Med; 2007 Jan; 48(1):15-21. PubMed ID: 17204694
[TBL] [Abstract][Full Text] [Related]
11. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?
Yau YY; Chan WS; Tam YM; Vernon P; Wong S; Coel M; Chu SK
J Nucl Med; 2005 Feb; 46(2):283-91. PubMed ID: 15695788
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?
Hellwig D; Graeter TP; Ukena D; Groeschel A; Sybrecht GW; Schaefers HJ; Kirsch CM
J Nucl Med; 2007 Nov; 48(11):1761-6. PubMed ID: 17942814
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
Uesaka D; Demura Y; Ishizaki T; Ameshima S; Miyamori I; Sasaki M; Fujibayashi Y; Okazawa H
J Nucl Med; 2008 Oct; 49(10):1606-12. PubMed ID: 18794269
[TBL] [Abstract][Full Text] [Related]
14. (18)F-FDG PET-CT respiratory gating in characterization of pulmonary lesions: approximation towards clinical indications.
García Vicente AM; Soriano Castrejón AM; Talavera Rubio MP; León Martín AA; Palomar Muñoz AM; Pilkington Woll JP; Poblete García VM
Ann Nucl Med; 2010 Apr; 24(3):207-14. PubMed ID: 20177834
[TBL] [Abstract][Full Text] [Related]
15. Comparison of objective criteria and expert visual interpretation to classify benign and malignant hilar and mediastinal nodes on 18-F FDG PET/CT.
Nguyen P; Bhatt M; Bashirzadeh F; Hundloe J; Ware R; Fielding D; Ravi Kumar AS
Respirology; 2015 Jan; 20(1):129-37. PubMed ID: 25263085
[TBL] [Abstract][Full Text] [Related]
16. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S
Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328
[TBL] [Abstract][Full Text] [Related]
17. Dual-time-point 18F-FDG PET/CT versus dynamic breast MRI of suspicious breast lesions.
Imbriaco M; Caprio MG; Limite G; Pace L; De Falco T; Capuano E; Salvatore M
AJR Am J Roentgenol; 2008 Nov; 191(5):1323-30. PubMed ID: 18941064
[TBL] [Abstract][Full Text] [Related]
18. Dual-time point 18F-FDG PET/CT scan for differentiation between 18F-FDG-avid non-small cell lung cancer and benign lesions.
Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N
Ann Nucl Med; 2009 Jul; 23(5):427-35. PubMed ID: 19437097
[TBL] [Abstract][Full Text] [Related]
19. Solid splenic masses: evaluation with 18F-FDG PET/CT.
Metser U; Miller E; Kessler A; Lerman H; Lievshitz G; Oren R; Even-Sapir E
J Nucl Med; 2005 Jan; 46(1):52-9. PubMed ID: 15632034
[TBL] [Abstract][Full Text] [Related]
20. Interobserver variability among measurements of the maximum and mean standardized uptake values on (18)F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors.
Huang YE; Chen CF; Huang YJ; Konda SD; Appelbaum DE; Pu Y
Acta Radiol; 2010 Sep; 51(7):782-8. PubMed ID: 20707663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]